CVKD
Cadrenal Therapeutics, Inc.
1.20$
-4.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 21.6% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 78.4% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 13,046.5% | – | – | – | 72,053.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 32,590.6% | – | – | – | 128,415.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 45,658.6% | – | – | – | 200,488.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -45,658.6% | – | – | – | -200,488.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 490.1% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -41,331.6% | – | – | – | -196,216.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -41,331.6% | – | – | – | -196,216.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -41,310.1% | – | – | – | -196,197.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.